Donor derived malignancy following transplantation: a review
Tóm tắt
Từ khóa
Tài liệu tham khảo
Ades L, Guardiola P, Socie G (2002) Second malignancies after allogeneic hematopoietic stem cell transplantation: new insight and current problems. Blood Rev 16(2):135–146
Alexander JW, Vaughn WK (1991) The use of “marginal” donors for organ transplantation. The influence of donor age on outcome. Transplantation 51(1):135–141
Armanios MY, Grossman SA, Yang SC, White B, Perry A, Burger PC, Orens JB (2004) Transmission of glioblastoma multiforme following bilateral lung transplantation from an affected donor: case study and review of the literature. Neuro-oncol 6(3):259–263
Au WY, Chan EC, Siu LL, Lau TC, Lie AK, Ma SK, Kwong YL (2002) Leukaemic relapse of donor origin after allogeneic bone marrow transplantation from a donor who later developed bronchogenic carcinoma. Br J Haematol 119(3):777–780
Au WY, Lam CC, Lie AK, Pang A, Kwong YL (2003) T-cell large granular lymphocyte leukemia of donor origin after allogeneic bone marrow transplantation. Am J Clin Pathol 120(4):626–630
Baehner R, Magrane G, Balassanian R, Chang C, Millward C, Wakil AE, Osorio RW, Waldman FM (2000) Donor origin of neuroendocrine carcinoma in 2 transplant patients determined by molecular cytogenetics. Hum Pathol 31(11):1425–1429
Baron F, Dresse MF, Beguin Y (2003) Transmission of chronic myeloid leukemia through peripheral-blood stem-cell transplantation. N Engl J Med 349(9):913–914
Barozzi P, Luppi M, Facchetti F, Mecucci C, Alu M, Sarid R, Rasini V, Ravazzini L, Rossi E, Festa S, Crescenzi B, Wolf DG, Schulz TF, Torelli G (2003) Post-transplant Kaposi sarcoma originates from the seeding of donor-derived progenitors. Nat Med 9(5):554–561
Barrou B, Bitker MO, Delcourt A, Ourahma S, Richard F (2001) Fate of a renal tubulopapillary adenoma transmitted by an organ donor. Transplantation 72(3):540–541
Berg KD, Brinster NK, Huhn KM, Goggins MG, Jones RJ, Makary A, Murphy KM, Griffin CA, Rosenblum-Vos LS, Borowitz MJ, Nousari HC, Eshleman JR (2001) Transmission of a T-cell lymphoma by allogeneic bone marrow transplantation. N Engl J Med 345(20):1458–1463
Bielorai B, Deeg HJ, Weintraub M, Neumann Y, Rosner E, Amariglio N, Rechavi G, Toren A (2003) B-cell lymphoma developing in the donor 9 years after donor-origin acute myeloid leukemia post bone marrow transplantation. Bone Marrow Transplant 31(10):931–934
Birkeland SA, Storm HH (2002) Risk for tumor and other disease transmission by transplantation: a population-based study of unrecognized malignancies and other diseases in organ donors. Transplantation 74(10):1409–1413
Blazar BR, Orr HT, Arthur DC, Kersey JH, Filipovich AH (1985) Restriction fragment length polymorphisms as markers of engraftment in allogeneic marrow transplantation. Blood 66(6):1436–1444
Bodo I, Peters M, Radich JP, Hess J, Blinder M, Watson MS, Van Rheeden R, Natarajan S, Lowell JA, Brown R, DiPersio J, Adkins D (1999) Donor-derived acute promyelocytic leukemia in a liver-transplant recipient. N Engl J Med 341(11):807–813
Bodvarsson S, Burlingham W, Kusaka S, Hafez GR, Becker BN, Pintar T, Sollinger HW, Albertini MR (2001) Donor-derived small cell lung carcinoma in a kidney transplant recipient. Cancer 92(9):2429–2434
Bosmans JL, Ysebaert D, De Cock AM, Hauben E, Muylle L, Schrijvers D, Van Marck E, Eyskens E, De Broe ME (1997) Interferon-alpha and the cure of metastasis of a malignant meningioma in a kidney allograft recipient: a case report. Transplant Proc 29(1–2):838
Botstein D, White RL, Skolnick M, Davis RW (1980) Construction of a genetic linkage map in man using restriction fragment length polymorphisms. Am J Hum Genet 32(3):314–331
Boyce T, Edwards J, Scarborough N (1999) Allograft bone. The influence of processing on safety and performance. Orthop Clin North Am 30(4):571–581
Boyd CN, Ramberg RC, Thomas ED (1982) The incidence of recurrence of leukemia in donor cells after allogeneic bone marrow transplantation. Leuk Res 6(6):833–837
Browne PV, Lawler M, Humphries P, McCann SR (1991) Donor-cell leukemia after bone marrow transplantation for severe aplastic anemia. N Engl J Med 325(10):710–713
Brunstein CG, Hirsch BA, Hammerschmidt D, McGlennen RC, Nguyen PL, Verfaillie CM (2002) Leukemia in donor cells after allogeneic hematopoietic stem cell transplant. Bone Marrow Transplant 29(12):999–1003
Buell JF, Trofe J, Hanaway MJ, Lo A, Rosengard B, Rilo H, Alloway R, Beebe T, First MR, Woodle ES (2001) Transmission of donor cancer into cardiothoracic transplant recipients. Surgery 130(4):660–666; discussion 666–668
Buell JF, Trofe J, Sethuraman G, Hanaway MJ, Beebe TM, Gross TG, Alloway R, First MR, Woodle ES (2003) Donors with central nervous system malignancies: are they truly safe? Transplantation 76(2):340–343
Buell JF, Beebe TM, Trofe J, Gross TG, Alloway RR, Hanaway MJ, Woodle ES (2004) Donor transmitted malignancies. Ann Transplant 9(1):53–56
Buell JF, Gross T, Alloway RR, Trofe J, Woodle ES (2005) Central nervous system tumors in donors: misdiagnosis carries a high morbidity and mortality. Transplant Proc 37(2):583–584
Campbell AN, Chan HS, Becker LE, Daneman A, Park TS, Hoffman HJ (1984) Extracranial metastases in childhood primary intracranial tumors. A report of 21 cases and review of the literature. Cancer 53(4):974–981
Cankovic M, Linden MD, Zarbo RJ (2006) Use of microsatellite analysis in detection of tumor lineage as a cause of death in a liver transplant patient. Arch Pathol Lab Med 130(4):529–532
Caspersson T, Zech L, Johansson C, Modest EJ (1970) Identification of human chromosomes by DNA-binding fluorescent agents. Chromosoma 30(2):215–227
Caspersson T, Lomakka G, Zech L (1972) The 24 fluorescence patterns of the human metaphase chromosomes - distinguishing characters and variability. Hereditas 67(1):89–102
Childress S (2006) Invasion of the body snatchers. Newsweek 147(10):46
Chui AK, Herbertt K, Wang LS, Kyd G, Hodgeman G, Verran DJ, DeLeon C, Sheil AG (1999) Risk of tumor transmission in transplantation from donors with primary brain tumors: an Australian and New Zealand registry report. Transplant Proc 31(1–2):1266–1267
Collignon FP, Holland EC, Feng S (2004) Organ donors with malignant gliomas: an update. Am J Transplant 4(1):15–21
Colquhoun SD, Robert ME, Shaked A, Rosenthal JT, Millis TM, Farmer DG, Jurim O, Busuttil RW (1994) Transmission of CNS malignancy by organ transplantation. Transplantation 57(6):970–974
Conlon PJ, Smith SR (1995) Transmission of cancer with cadaveric donor organs. J Am Soc Nephrol 6(1):54–60
Cooley LD, Sears DA, Udden MM, Harrison WR, Baker KR (2000) Donor cell leukemia: report of a case occurring 11 years after allogeneic bone marrow transplantation and review of the literature. Am J Hematol 63(1):46–53
Cransac M, Boiron JM, Merel P, Cony-Makhoul P, Marit G, Bernard P, Ferrer J, Reiffers J (1993) Burkitt-type acute lymphoblastic leukemia in donor cells after allogeneic bone marrow transplantation for acute nonlymphoblastic leukemia. Transplantation 56(1):120–123
Cullis JO, Marks DI, Schwarer AP, Barrett AJ, Hows JM, Swirsky DM, Goldman JM (1992) Relapse into blast crisis following bone marrow transplantation for chronic phase chronic myeloid leukaemia: a report of five cases. Br J Haematol 81(3):378–382
Curtis RE, Rowlings PA, Deeg HJ, Shriner DA, Socie G, Travis LB, Horowitz MM, Witherspoon RP, Hoover RN, Sobocinski KA, Fraumeni JF Jr, Boice JD Jr (1997) Solid cancers after bone marrow transplantation. N Engl J Med 336(13):897–904
Curtis RE, Travis LB, Rowlings PA, Socie G, Kingma DW, Banks PM, Jaffe ES, Sale GE, Horowitz MM, Witherspoon RP, Shriner DA, Weisdorf DJ, Kolb HJ, Sullivan KM, Sobocinski KA, Gale RP, Hoover RN, Fraumeni JF Jr, Deeg HJ (1999) Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study. Blood 94(7):2208–2216
Deeg HJ, Sanders J, Martin P, Fefer A, Neiman P, Singer J, Storb R, Thomas ED (1984) Secondary malignancies after marrow transplantation. Exp Hematol 12(8):660–666
Deeg HJ, Socie G (1998) Malignancies after hematopoietic stem cell transplantation: many questions, some answers. Blood 91(6):1833–1844
Detry O, Honore P, Hans MF, Delbouille MH, Jacquet N, Meurisse M (2000) Organ donors with primary central nervous system tumor. Transplantation 70(1):244–248; discussion 251–242
Detry O, De Roover A, de Leval L, Herens C, Delwaide J, Honore P, Meurisse M (2005) Transmission of an undiagnosed sarcoma to recipients of kidney and liver grafts procured in a non-heart beating donor. Liver Transpl 11(6):696–699
Donovan JA, Simmons FA, Esrason KT, Jamehdor M, Busuttil RW, Novak JM, Grody WW (1997) Donor origin of a posttransplant liver allograft malignancy identified by fluorescence in situ hybridization for the Y chromosome and DNA genotyping. Transplantation 63(1):80–84
Edwards A, Civitello A, Hammond HA, Caskey CT (1991) DNA typing and genetic mapping with trimeric and tetrameric tandem repeats. Am J Hum Genet 49(4):746–756
Elfenbein GJ, Brogaonkar DS, Bias WB, Burns WH, Saral R, Sensenbrenner LL, Tutschka PJ, Zaczek BS, Zander AR, Epstein RB, Rowley JD, Santos GW (1978) Cytogenetic evidence for recurrence of acute myelogenous leukemia after allogeneic bone marrow transplantation in donor hematopoietic cells. Blood 52(3):627–636
Elmaagacli AH, Freist A, Hahn M, Opalka B, Seeber S, Schaefer UW, Beelen DW (2001) Estimating the relapse stage in chronic myeloid leukaemia patients after allogeneic stem cell transplantation by the amount of BCR-ABL fusion transcripts detected using a new real-time polymerase chain reaction method. Br J Haematol 113(4):1072–1075
Fecteau AH, Penn I, Hanto DW (1998) Peritoneal metastasis of intracranial glioblastoma via a ventriculoperitoneal shunt preventing organ retrieval: case report and review of the literature. Clin Transplant 12(4):348–350
Feig SA, Dreazen O, Simon M, Wiley F, Schreck R, Gale RP (1988) B cell acute lymphoblastic leukemia (ALL) in donor cells following bone marrow transplantation for T cell ALL. Bone Marrow Transplant 3(4):331–337
Feng S, Buell JF, Cherikh WS, Deng MC, Hanto DW, Kauffman HM, Leichtman AB, Lorber MI, Maters RG, McBride MA, Metzger RA, Nolte FS, O’Connor KJ, Roth D, Terrault NA, Henry ML (2002) Organ donors with positive viral serology or malignancy: risk of disease transmission by transplantation. Transplantation 74(12):1657–1663
Feng S, Buell JF, Chari RS, DiMaio JM, Hanto DW (2003) Tumors and transplantation: The 2003 Third Annual ASTS State-of-the-Art Winter Symposium. Am J Transplant 3(12):1481–1487
Fialkow PJ, Thomas ED, Bryant JI, Neiman PE (1971) Leukaemic transformation of engrafted human marrow cells in vivo. Lancet 1(7693):251–255
Fiorentino M, D’Errico A, Corti B, Casanova S, Ridolfi L, Venturoli N, Sestigiani E, Grigioni WF (2003) A multiorgan donor cancer screening protocol: the Italian Emilia-Romagna region experience. Transplantation 76(12):1695–1699
Flemming P, Tillmann HL, Barg-Hock H, Kleeberger W, Manns MP, Klempnauer J, Kreipe HH (2003) Donor origin of de novo hepatocellular carcinoma in hepatic allografts. Transplantation 76(5):871–873
Frank S, Muller J, Bonk C, Haroske G, Schackert HK, Schackert G (1998) Transmission of glioblastoma multiforme through liver transplantation. Lancet 352(9121):31
Gerstenkorn C, Thomusch O (2003) Transmission of a pancreatic adenocarcinoma to a renal transplant recipient. Clin Transplant 17(5):473–476
Giannoudis PV, Dinopoulos H, Tsiridis E (2005) Bone substitutes: an update. Injury 36(Suppl 3):S20–27
Goh K, Klemperer MR (1977) In vivo leukemic transformation: cytogenetic evidence of in vivo leukemic transformation of engrafted marrow cells. Am J Hematol 2(3):283–290
Gopcsa L, Barta A, Banyai A, Konya M, Pajor L, Foldi J, Paloczi K (2002) Acute myeloid leukaemia of donor cell origin developing 5 years after allogeneic bone marrow transplantation for chronic myeloid leukaemia. Bone Marrow Transplant 29(5):449–452
Gossett TC, Gale RP, Fleischman H, Austin GE, Sparkes RS, Taylor CR (1979) Immunoblastic sarcoma in donor cells after bone-marrow transplantation. N Engl J Med 300(16):904–907
Haltrich I, Muller J, Szabo J, Kovacs G, Koos R, Poros A, Dobos M, Fekete G (2003) Donor-cell myelodysplastic syndrome developing 13 years after marrow grafting for aplastic anemia. Cancer Genet Cytogenet 142(2):124–128
Harrison DA, Hodge DO, Bourne WM (1995) Outcome of corneal grafting with donor tissue from eyes with primary choroidal melanomas. A retrospective cohort comparison. Arch Ophthalmol 113(6):753–756
Hertenstein B, Hambach L, Bacigalupo A, Schmitz N, McCann S, Slavin S, Gratwohl A, Ferrant A, Elmaagacli A, Schwertfeger R, Locasciulli A, Zander A, Bornhauser M, Niederwieser D, Ruutu T (2005) Development of leukemia in donor cells after allogeneic stem cell transplantation—a survey of the European Group for Blood and Marrow Transplantation (EBMT). Haematologica 90(7):969–975
Heyligers IC, Klein-Nulend J (2005) Detection of living cells in non-processed but deep-frozen bone allografts. Cell Tissue Bank 6(1):25–31
Heyll A, Meckenstock G, Aul C, Sohngen D, Borchard F, Hadding U, Modder U, Leschke M, Schneider W (1994) Possible transmission of sarcoidosis via allogeneic bone marrow transplantation. Bone Marrow Transplant 14(1):161–164
Hoffman HJ, Duffner PK (1985) Extraneural metastases of central nervous system tumors. Cancer 56(7 Suppl):1778–1782
Hornik L, Tenderich G, Wlost S, Zittermann A, Minami K, Koerfer R (2004) Organs from donors with primary brain malignancy: the fate of cardiac allograft recipients. Transplant Proc 36(10):3133–3137
Jeffreys AJ, Wilson V, Thein SL (1985) Hypervariable ‘minisatellite’ regions in human DNA. Nature 314(6006):67–73
Jonas S, Bechstein WO, Lemmens HP, Neuhaus R, Thalmann U, Neuhaus P (1996) Liver graft-transmitted glioblastoma multiforme. A case report and experience with 13 multiorgan donors suffering from primary cerebral neoplasia. Transpl Int 9(4):426–429
Kakar S, Burgart LJ, Charlton MR, Saito Y, Halling K, Thibodeau SN (2002) Origin of adenocarcinoma in a transplanted liver determined by microsatellite analysis. Hum Pathol 33(4):435–436
Kalble T, Lucan M, Nicita G, Sells R, Burgos Revilla FJ, Wiesel M (2005) EAU guidelines on renal transplantation. Eur Urol 47(2):156–166
Kasiske BL, Cangro CB, Hariharan S, Hricik DE, Kerman RH, Roth D, Rush DN, Vazquez MA, Weir MR (2001) The evaluation of renal transplantation candidates: clinical practice guidelines. Am J Transplant 1 2(suppl): 3–95
Katz F, Reeves BR, Alexander S, Kearney L, Chessells J (1993) Leukaemia arising in donor cells following allogeneic bone marrow transplantation for beta thalassaemia demonstrated by immunological, DNA and molecular cytogenetic analysis. Br J Haematol 85(2):326–331
Kauffman HM, McBride MA, Graham WK, Wolf JS, Ellison MD, Daily OP (1997) United Network for Organ Sharing Donor Data Update, 1988–1995. Transplant Proc 29(1–2):122–124
Kauffman HM, McBride MA, Delmonico FL (2000) First report of the United Network for Organ Sharing Transplant Tumor Registry: donors with a history of cancer. Transplantation 70(12):1747–1751
Kauffman HM, McBride MA, Delmonico FL (2001) UNOS Transplant Tumor Registry: donors with a history of cancer. Transplant Proc 33(1–2):1844–1845
Kauffman HM, McBride MA, Cherikh WS, Spain PC, Delmonico FL (2002a) Transplant tumor registry: donors with central nervous system. Transplantation 73(4):579–582
Kauffman HM, McBride MA, Cherikh WS, Spain PC, Marks WH, Roza AM (2002b) Transplant tumor registry: donor related malignancy. Transplantation 74(3):358–362
Komeno Y, Kanda Y, Kandabashi K, Kawazu M, Goyama S, Takeshita M, Nannya Y, Niino M, Nakamoto T, Kurokawa M, Tsujino S, Ogawa S, Aoki K, Chiba S, Motokura T, Hirai H (2003) Reduced-intensity bone marrow transplantation from an alternative unrelated donor for myelodysplastic syndrome of first-donor origin. Am J Hematol 72(3):220–222
Konigsrainer A, Steurer W, Schumer J, Geissler D, Mourad M, Squifflet JP, Margreiter R (1993) Transmission of non-Hodgkin’s lymphoma through renal allografts–disastrous result of false diagnosis and inadequate information. Transplant Proc 25(6):3075–3076
Kumar S, Daniel J, Khan S, Heifets M, Ranganna K, Subramanian S, Daniel S, Kumar A (2006) Successful transplantation of kidneys from deceased donors with past non-skin malignancies with out transmission of donor cancer. World Transplant Congress, Boston, MA
Lefrancois N, Touraine JL, Cantarovich D, Cantarovich F, Faure JL, Dubernard JM, Dureau G, Colpart JJ, Bouvier R, Traeger J (1987) Transmission of medulloblastoma from cadaver donor to three organ transplant recipients. Transplant Proc 19(1 Pt 3):2242
Lipshutz GS, Baxter-Lowe LA, Nguyen T, Jones KD, Ascher NL, Feng S (2003) Death from donor-transmitted malignancy despite emergency liver retransplantation. Liver Transpl 9(10):1102–1107
Loren AW, Desai S, Gorman RC, Schuchter LM (2003) Retransplantation of a cardiac allograft inadvertently harvested from a donor with metastatic melanoma. Transplantation 76(4):741–743
Lowsky R, Fyles G, Minden M, Lipton J, Meharchand J, Tejpar I, Zipursky A, Messner H (1996) Detection of donor cell derived acute myelogenous leukaemia in a patient transplanted for chronic myelogenous leukaemia using fluorescence in situ hybridization. Br J Haematol 93(1):163–165
Marmont A, Frassoni F, Bacigalupo A, Podesta M, Piaggio G, Van Lint MT, Caimo A, de Filippi S (1984) Recurrence of Ph’-positive leukemia in donor cells after marrow transplantation for chronic granulocytic leukemia. N Engl J Med 310(14):903–906
Martin DC, Rubini M, Rosen VJ (1965) Cadaveric renal homotransplantation with inadvertent transplantation of carcinoma. JAMA 192:752–754
Matter B, Zukoski CF, Killen DA, Ginn E (1970) Transplanted carcinoma in an immunosuppressed patient. Transplantation 9(1):71–74
McCann SR, Lawler M (1993) Mixed chimaerism; detection and significance following BMT. Bone Marrow Transplant 11(2):91–94
McCann SR, Lawler M, Humphries P, Bacigalupo A, Podesta M, Frassoni F, Van Lint MT, Marmont A (1992) Recurrence of Philadelphia chromosome-positive leukemia in donor cells after marrow transplantation for chronic granulocytic leukemia: confirmation by microsatellite studies. Blood 79(10):2803–2805
McGeorge AJ, Vote BJ, Elliot DA, Polkinghorne PJ (2002) Papillary adenocarcinoma of the iris transmitted by corneal transplantation. Arch Ophthalmol 120(10):1379–1383
Medical Standards (1999) Eye Bank Association of America
Mendez JC, Paya CV (2000) Kaposi’s sarcoma and transplantation. Herpes 7(1):18–23
Mielcarek M, Bryant E, Loken M, Torok-Storb B, Storb R (1999) Haemopoietic reconstitution by donor-derived myelodysplastic progenitor cells after haemopoietic stem cell transplantation. Br J Haematol 105(2):361–365
Milton CA, Barbara J, Cooper J, Rao M, Russell C, Russ G (2006) The transmission of donor-derived malignant melanoma to a renal allograft recipient. Clin Transplant 20(5):547–550
Morath C, Rohmeiss P, Schwenger V, Waldherr R, Ritz E, Zeier M, Fallsehr C, Kloor M, von Knebel Doeberitz M, Andrassy J, Huckenbeck W, Buchler M, Opelz G (2005) Transmission of donor-derived small-cell carcinoma cells by a nontumor-bearing allograft. Transplantation 80(4):540–542
Morath C, Schwenger V, Schmidt J, Zeier M (2005) Transmission of malignancy with solid organ transplants. Transplantation 80(1 Suppl):S164–166
Morris-Stiff G, Steel A, Savage P, Devlin J, Griffiths D, Portman B, Mason M, Jurewicz WA (2004) Transmission of donor melanoma to multiple organ transplant recipients. Am J Transplant 4(3):444–446
Morse JH, Turcotte JG, Merion RM, Campbell DA Jr, Burtch GD, Lucey MR (1990) Development of a malignant tumor in a liver transplant graft procured from a donor with a cerebral neoplasm. Transplantation 50(5):875–877
Mouratidou M, Sotiropoulos D, Deremitzaki K, Spathas DH, Hoffbrand AV, Prentice HG, Papanastasiou K, Tsakanikas S, Tsaftaridis P, Stamatelou M et al (1993) Recurrence of acute leukemia in donor cells after bone marrow transplantation: documentation by in situ DNA hybridization. Bone Marrow Transplant 12(1):77–80
Neipp M, Schwarz A, Pertschy S, Klempnauer J, Becker T (2006) Accidental transplantation of a kidney with a cystic renal cell carcinoma following living donation: management and 1 yr follow-up. Clin Transplant 20(2):147–150
Newburger PE, Latt SA, Pesando JM, Gustashaw K, Powers M, Chaganti RS, O’Reilly RJ (1981) Leukemia relapse in donor cells after allogeneic bone-marrow transplantation. N Engl J Med 304(12):712–714
Niederwieser DW, Appelbaum FR, Gastl G, Gersdorf E, Meister B, Geissler D, Tratkiewicz JA, Thaler J, Huber C (1990) Inadvertent transmission of a donor’s acute myeloid leukemia in bone marrow transplantation for chronic myelocytic leukemia. N Engl J Med 322(25):1794–1796
Niederwieser D, Gentilini C, Hegenbart U, Lange T, Moosmann P, Ponisch W, Al-Ali H, Raida M, Ljungman P, Tyndall A, Urbano-Ispizua A, Lazarus HM, Gratwohl A (2004) Transmission of donor illness by stem cell transplantation: should screening be different in older donors? Bone Marrow Transplant 34(8):657–665
Oesterwitz HE, Lucius K (1991) Transmission of cancer with cadaveric donor kidneys. Transplant Proc 23(5):2647
Palka G, Di Bartolomeo P, Iacone A, Di Girolamo G, Betti S, Calabrese G, Natale D, Stuppia L, Rieve AK, Torlontano G (1986) Cytogenetics and bone marrow transplantation. Cancer Genet Cytogenet 21(2):147–157
Palka G, Calabrese G, Di Girolamo G, Stuppia L, Di Bartolomeo P, Guanciali Franchi P, Di Virgilio C, Bianchi GP, Angrilli F, Parruti G et al (1991) Cytogenetic survey of 31 patients treated with bone marrow transplantation for acute nonlymphocytic and acute lymphoblastic leukemias. Cancer Genet Cytogenet 51(2):223–233
Palmer SH, Gibbons CL, Athanasou NA (1999) The pathology of bone allograft. J Bone Joint Surg Br 81(2):333–335
Pasquier B, Pasquier D, N’Golet A, Panh MH, Couderc P (1980) Extraneural metastases of astrocytomas and glioblastomas: clinicopathological study of two cases and review of literature. Cancer 45(1):112–125
Penn I (1975) The incidence of malignancies in transplant recipients. Transplant Proc 7(2):323–326
Penn I (1991) Donor transmitted disease: cancer. Transplant Proc 23(5):2629–2631
Penn I (1995) Primary kidney tumors before and after renal transplantation. Transplantation 59(4):480–485
Penn I (1997) Transmission of cancer from organ donors. Ann Transplant 2(4):7–12
Penn I, Halgrimson CG, Starzl TE (1971) De novo malignant tumors in organ transplant recipients. Transplant Proc 3(1):773–778
Peri N, Kussick S, Bakthavatsalam R, Mitsumori L, Dighe M (2006) Postrenal transplant non-EBV multiple myeloma of donor origin. Am J Transplant 6(2):419–422
Perry A (2005) In: Pfeifer JD (ed) Molecular genetic testing in surgical pathology, 1st edn, Volume Chapter 4. Lippincott Williams & Wilkins, pp 72–85
Pokorna E, Vitko S (2001) The fate of recipients of organs from donors with diagnosis of primary brain tumor. Transpl Int 14(5):346–347
Reichard KK, Zhang QY, Sanchez L, Hozier J, Viswanatha D, Foucar K (2006) Acute myeloid leukemia of donor origin after allogeneic bone marrow transplantation for precursor T-cell acute lymphoblastic leukemia: case report and review of the literature. Am J Hematol 81(3):178–185
Roza AM, Johnson C, Juckett M, Eckels D, Adams M (2001) Adenocarcinoma arising in a transplanted pancreas. Transplantation 72(6):1156–1157
Ruiz JC, Cotorruelo JG, Tudela V, Ullate PG, Val-Bernal F, de Francisco AL, Zubimendi JA, Prieto M, Canga E, Arias M (1993) Transmission of glioblastoma multiforme to two kidney transplant recipients from the same donor in the absence of ventricular shunt. Transplantation 55(3):682–683
Sack FU, Lange R, Mehmanesh H, Amman K, Schnabel P, Zimmermann R, Dengler T, Otto HF, Hagl S (1997) Transferral of extrathoracic donor neoplasm by the cardiac allograft. J Heart Lung Transplant 16(3):298–301
Sala-Torra O, Hanna C, Loken MR, Flowers ME, Maris M, Ladne PA, Mason JR, Senitzer D, Rodriguez R, Forman SJ, Deeg HJ, Radich JP (2006) Evidence of donor-derived hematologic malignancies after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 12(5):511–517
Salame N, Viel JF, Arveux P, Delbosc B (2001) Cancer transmission through corneal transplantation. Cornea 20(7):680–682
Schmitz N, Johannson W, Schmidt G, von der Helm K, Loffler H (1987) Recurrence of acute lymphoblastic leukemia in donor cells after allogeneic marrow transplantation associated with a deletion of the long arm of chromosome 6. Blood 70(4):1099–1104
Select Committee of Experts on the Organisational Aspects of Cooperation in Organ Transplantation (1997) Council of Europe. International Consensus Document Standadization of Organ Donor Screening to Prevent transmission of Neoplastic Diseases
Serralta AS, Orbis FC, Sanjuan FR, Moya AH, Lopez-Andujar R, Pareja EI, Vila JC, Juan MB, Mir JP (2003) If the donor had an early-stage genitourinary carcinoma and the liver has already been implanted, should we perform the transplantectomy? Liver Transpl 9(12):1281–1285
Smith JL, Heerema NA, Provisor AJ (1985) Leukaemic transformation of engrafted bone marrow cells. Br J Haematol 60(3):415–422
Spinelli O, Giussani U, Borleri G, Lazzari M, Michelato A, Dotti G, Barbui T, Rambaldi A (2000) Need for an accurate molecular diagnosis to assess the donor origin of leukemia relapse after allogeneic stem cell transplantation. Haematologica 85(11):1153–1157
Stephens JK, Everson GT, Elliott CL, Kam I, Wachs M, Haney J, Bartlett ST, Franklin WA (2000) Fatal transfer of malignant melanoma from multiorgan donor to four allograft recipients. Transplantation 70(1):232–236
Taylor AL, Marcus R, Bradley JA (2005) Post-transplant lymphoproliferative disorders (PTLD) after solid organ transplantation. Crit Rev Oncol Hematol 56(1):155–167
Thomas ED, Bryant JI, Buckner CD, Clift RA, Fefer A, Johnson FL, Neiman P, Ramberg RE, Storb R (1972) Leukaemic transformation of engrafted human marrow cells in vivo. Lancet 1(7764):1310–1313
Thomas ED, Bryant JI, Buckner CD, Clift RA, Fefer A, Neiman P, Ramberg RE, Storb R (1972) Leukemic transformation of engrafted human marrow. Transplant Proc 4(4):567–570
Val-Bernal F, Ruiz JC, Cotorruelo JG, Arias M (1993) Glioblastoma multiforme of donor origin after renal transplantation: report of a case. Hum Pathol 24(11):1256–1259
Wagoner MD, Dohlman CH, Albert DM, Lavin P, Murphy A, O’Neill-Dryja M (1981) Corneal donor material selection. Ophthalmology 88(2):139–145
Wallace CJ, Forsyth PA, Edwards DR (1996) Lymph node metastases from glioblastoma multiforme. AJNR Am J Neuroradiol 17(10):1929–1931
Weyts FA, Bos PK, Dinjens WN, van Doorn WJ, van Biezen FC, Weinans H, Verhaar JA (2003) Living cells in 1 of 2 frozen femoral heads. Acta Orthop Scand 74(6):661–664
Wilson RE, Penn I (1975) Fate of tumors transplanted with a renal allograft. Transplant Proc 7(2):327–331
Wilson RE, Hager EB, Hampers CL, Corson JM, Merrill JP, Murray JE (1968) Immunologic rejection of human cancer transplanted with a renal allograft. N Engl J Med 278(9):479–483
Winter TC, Keller PR, Lee FT Jr, Pozniak MA (2001) Donor-derived malignancy: transmission of small-cell lung cancer via renal transplantation. J Ultrasound Med 20(5):559–562
Witherow BA, Roth GS, Carrozza MA, Freyberg RW, Kopke JE, Alloway RR, Buell JF, First MR, Gross TG, Hanaway MJ, Trofe J, Woodle ES, Beebe TM (2003) The Israel Penn International Transplant Tumor Registry. AMIA Annu Symp Proc, p. 1053
Witherspoon RP, Schubach W, Neiman P, Martin P, Thomas ED (1985) Donor cell leukemia developing six years after marrow grafting for acute leukemia. Blood 65(5):1172–1174
Zaccaria A, Rosti G, Testoni N, Arnold R, Bandini G, Becher R, Boogaerts M, Carbonell F, Di Bartolomeo P, Ferrant A et al (1987) Chromosome studies in patients with acute nonlymphocytic or acute lymphocytic leukemia submitted to bone marrow transplantation–results of a European cooperative study. Cancer Genet Cytogenet 26(1):51–58